Clinicopathological study of dementia : the Hisayama study
痴呆症的临床病理学研究:久山研究
基本信息
- 批准号:16300112
- 负责人:
- 金额:$ 8.06万
- 依托单位:
- 依托单位国家:日本
- 项目类别:Grant-in-Aid for Scientific Research (B)
- 财政年份:2004
- 资助国家:日本
- 起止时间:2004 至 2006
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
The Hisayama study is a prospective population-based clinicopathological cohort in a Japanese subrural community, Hisayama Town. Most deceased subjects have been examined by autopsy to confirm causes of death and to examine brain pathology. These features have allowed a reliable estimation of the frequency of neurodegenerative diseases relating dementia in a general population and for a detailed analysis of the difference between dementia and non-dementia. In this study we obtained following findings.(1)We have estimated the frequency of senile dementia of the neurofibrillary tangle type (SD-NFT), which was fourth frequent type of dementia (3.9%). We found that the number of NFTs in the hippocampus of SD-NFT cases did not necessarily exceed the degree of those in Alzheimer's disease and that total brain weights were significantly reduced to the same extent as Alzheimer's disease (AD), which suggest that not only the limbic NFT pathology but also some whole brain dysfunctions might caus … More e the mental deterioration.(2)To explore cyclooxygenase(COX)-2 expression in the hippocampus, we analyzed 45 consecutive autopsy subjects without dementia and 25 AD patients. The neuronal expression of COX-2 in the CA3 subdivision of the hippocampus, subiculum, entorhinal cortex and transentorhinal cortex were consistently observed in both non-demented and AD brains and COX-2 immunoreactivity correlated with age in non-demented brains. In AD patients, neurons of CA1 exhibited increased COX-2 immunoreactivity which correlated with the severity of AD pathology, this correlation was not apparent in non-demented subjects. The results suggest that COX-2 expression may be differentially regulated among subdivisions of the hippocampus and that elevated COX-2 expression in the CA1 of AD brains may be associated with AD pathology and thus cognitive dysfunction.(3)Dementia with Lewy bodies (DLB) ranks the third major dementia. To verify the validity of the revised criteria in 2005, we have analyzed 205 consecutive demented autopsy cases. LB pathology was present in 59 cases (28.8%). Female cases with DLB have a tendency for more severe LB pathology and Alzheimer-type pathology as well. The high likelihood cases and intermediate cases exhibited 0.44 and 0.94 of 3 clinical core features each on average, respectively. On the other hand, the low likelihood cases and the LB-negative cases showed only 0.19 and 0.18 each. In conclusion, it is appropriate to include both the high likelihood and intermediate cases for diagnosis of DLB. Less
久山研究是在日本郊区社区久山镇进行的一项基于人群的前瞻性临床病理学队列,大多数死亡受试者都经过尸检,以确认死亡原因并检查大脑病理学。这些特征可以对死亡频率进行可靠估计。在一般人群中与痴呆相关的神经退行性疾病以及对痴呆和非痴呆之间的差异的详细分析在这项研究中,我们获得了以下发现。(1)我们估计了神经原纤维老年痴呆的频率。缠结型(SD-NFT),这是第四种常见的痴呆类型(3.9%),我们发现SD-NFT病例海马中NFT的数量不一定超过阿尔茨海默病患者和整个大脑的程度。体重显着下降,程度与阿尔茨海默病(AD)相同,这表明不仅边缘系统 NFT 病理学而且一些全脑功能障碍也可能导致精神恶化。(2)探索我们分析了 45 名无痴呆的连续尸检受试者和 25 名 AD 患者的海马中环氧合酶(COX)-2 的表达情况,结果一致地观察到 COX-2 在海马 CA3 分区、下托、内嗅皮层和经内嗅皮层的神经元表达。非痴呆和 AD 大脑中的 COX-2 免疫反应性与非痴呆大脑中的年龄相关。 CA1 显示 COX-2 免疫反应性增加,这与 AD 病理的严重程度相关,但这种相关性在非痴呆受试者中并不明显。结果表明,COX-2 表达可能在海马各分区之间受到差异性调节,并且 COX-2 升高。 AD大脑CA1区的表达可能与AD病理进而导致认知功能障碍有关。(3)路易体痴呆(DLB)位列第三位主要痴呆。 验证修订后的标准的有效性。 2005年,我们分析了205例连续的痴呆LB病理,其中59例(28.8%)女性病例有更严重的LB病理和阿尔茨海默型病理的倾向。 3 个临床核心特征的平均分别为 0.44 和 0.94,而低可能性病例和 LB 阴性病例仅显示 0.19 和 0.94。总之,诊断 DLB 时应包括高可能性病例和中等可能性病例。
项目成果
期刊论文数量(16)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Aluminum chloride does not facilitate deposition of human synthetic amyloid beta 1-42 peptide in the rat ventricular system of a short-term infusion model.
氯化铝不会促进人合成淀粉样β1-42肽在短期输注模型的大鼠心室系统中的沉积。
- DOI:
- 发表时间:2005
- 期刊:
- 影响因子:0
- 作者:Saito;H.;Somogyi J;Nakagawa Y
- 通讯作者:Nakagawa Y
Styrylbenzoazole derivatives for imaging of prion plaques and treatment of transmissible spongiform encephalopatheis.
苯乙烯基苯并唑衍生物,用于朊病毒斑成像和传染性海绵状脑病的治疗。
- DOI:
- 发表时间:2006
- 期刊:
- 影响因子:0
- 作者:Toyoshima Y;Onodera O;Yamada M;Tsuji S;Kozak JA;Kozak JA;Matsushita M;Michiue H;Matsushita M;Wu HY;Michiue H;Matsushita M;Wu HY;Michiue H;Noguchi H;Wu HY;Matsushita M;Arataki S;Michiue H;Fujimi K;Fujimi K;Fujimi K;Sasaki K;Noda K;Ishikawa K
- 通讯作者:Ishikawa K
Surface plasmon resonance analysis for the screening of anti-piron compounds.
用于筛选抗 Piron 化合物的表面等离子共振分析。
- DOI:
- 发表时间:2006
- 期刊:
- 影响因子:0
- 作者:Toyoshima Y;Onodera O;Yamada M;Tsuji S;Kozak JA;Kozak JA;Matsushita M;Michiue H;Matsushita M;Wu HY;Michiue H;Matsushita M;Wu HY;Michiue H;Noguchi H;Wu HY;Matsushita M;Arataki S;Michiue H;Fujimi K;Fujimi K;Fujimi K;Sasaki K;Noda K;Ishikawa K;Kawatake S
- 通讯作者:Kawatake S
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
IWAKI Toru其他文献
IWAKI Toru的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('IWAKI Toru', 18)}}的其他基金
Molecular analysis of prion protein oligomers by single molecule fluorescence imaging
通过单分子荧光成像对朊病毒蛋白寡聚体进行分子分析
- 批准号:
24650186 - 财政年份:2012
- 资助金额:
$ 8.06万 - 项目类别:
Grant-in-Aid for Challenging Exploratory Research
Association of life-style related risk factors with the pathology of dementia
生活方式相关危险因素与痴呆病理的关联
- 批准号:
22300116 - 财政年份:2010
- 资助金额:
$ 8.06万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Clinicopathological study of risk factors for degenerative dementia : the Hisayama Study
退行性痴呆危险因素的临床病理学研究:久山研究
- 批准号:
19300125 - 财政年份:2007
- 资助金额:
$ 8.06万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Molecular changes at the posterior horn of spinal cord resulting from spinal root avulsion
脊髓根撕脱引起的脊髓后角的分子变化
- 批准号:
12680733 - 财政年份:2000
- 资助金额:
$ 8.06万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Molecular analysis of tumorigenesis human ependymoma.
人室管膜瘤肿瘤发生的分子分析。
- 批准号:
10670163 - 财政年份:1998
- 资助金额:
$ 8.06万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Function of alphaB-crystallin in brain development and neurodegeneration
αB-晶状体蛋白在大脑发育和神经退行性变中的功能
- 批准号:
06454694 - 财政年份:1994
- 资助金额:
$ 8.06万 - 项目类别:
Grant-in-Aid for General Scientific Research (B)
Accumulation of alphaB-crystallin in glioma cells and the relation to oncogene expression.
胶质瘤细胞中αB-晶状体蛋白的积累及其与癌基因表达的关系。
- 批准号:
04670213 - 财政年份:1992
- 资助金额:
$ 8.06万 - 项目类别:
Grant-in-Aid for General Scientific Research (C)
Molecular analysis of alphaB-crystallin in central nervous system and in pathologic conditions.
中枢神经系统和病理条件下 αB-晶状体蛋白的分子分析。
- 批准号:
02670154 - 财政年份:1990
- 资助金额:
$ 8.06万 - 项目类别:
Grant-in-Aid for General Scientific Research (C)
相似国自然基金
阿尔茨海默病早期认知功能下降病情演化临界预警模型研究
- 批准号:82371484
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
基于空间代谢流技术探究人参-远志药对通过纠偏单胺类神经递质代谢紊乱治疗阿尔茨海默病的整合作用模式
- 批准号:82304894
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
SETDB1调控小胶质细胞功能及参与阿尔茨海默病发病机制的研究
- 批准号:82371419
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
小胶质细胞特异罕见易感突变介导相分离影响阿尔茨海默病发病风险的机制
- 批准号:82371438
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
GFAP-C291棕榈酰化激活星型胶质细胞在阿尔茨海默病中的作用和机制及干预研究
- 批准号:32371309
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
相似海外基金
Discovering early biomarkers of Alzheimer's disease using genetic and physics-informed networks
利用遗传和物理信息网络发现阿尔茨海默病的早期生物标志物
- 批准号:
2904538 - 财政年份:2024
- 资助金额:
$ 8.06万 - 项目类别:
Studentship
The Canadian Brain Health and Cognitive Impairment in Aging Knowledge Mobilization Hub: Sharing Stories of Research
加拿大大脑健康和老龄化认知障碍知识动员中心:分享研究故事
- 批准号:
498288 - 财政年份:2024
- 资助金额:
$ 8.06万 - 项目类别:
Operating Grants
Deciphering electrophysiological Alzheimer's Disease biomarkers for early diagnosis using interpretable deep learning
使用可解释的深度学习破译电生理阿尔茨海默病生物标志物以进行早期诊断
- 批准号:
24K18602 - 财政年份:2024
- 资助金额:
$ 8.06万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
DMS/NIGMS 1: Multilevel stochastic orthogonal subspace transformations for robust machine learning with applications to biomedical data and Alzheimer's disease subtyping
DMS/NIGMS 1:多级随机正交子空间变换,用于稳健的机器学习,应用于生物医学数据和阿尔茨海默病亚型分析
- 批准号:
2347698 - 财政年份:2024
- 资助金额:
$ 8.06万 - 项目类别:
Continuing Grant
Investigating And Targeting Microglial Senescence In Alzheimer's Disease
研究并针对阿尔茨海默病中的小胶质细胞衰老
- 批准号:
MR/Y004116/1 - 财政年份:2024
- 资助金额:
$ 8.06万 - 项目类别:
Research Grant